• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

EOFlow submits wearable, disposable insulin patch pump for FDA 510(k) clearance

January 9, 2023 By Sean Whooley

EOFlow EOPatch insulin patch
[Image from the EOFlow website]
EOFlow announced recently that it submitted a 510(k) application to the FDA for its EOPatch wearable, disposable insulin pump.

San Jose, California-based EOFlow submitted its application on Dec. 27, 2022. It aims to enter the U.S. diabetes market, expanding its reach outside Korea.

The company said in a news release that over 600 people in Korea use the EOPatch. Its adoption steadily increased despite no national health insurance coverage since its launch in April 2021. EOPatch features a reservoir size of 2 mL for insulin. The company also has FDA breakthrough device designation on a wearable, integrated artificial pancreas. The wearable, disposable device features a glucose monitoring sensor, insulin pump and automated insulin delivery algorithm.

EOFlow also officially launched the patch pump in Europe in September and obtained United Arab Emirates approval that same month. It picked up Indonesian approval in October 2022 as well. The company’s next step, American clearance, could come following submission, although the company said it does not know when to expect clearance.

EOFlow’s plans for the now-submitted technology

It plans to create a commercial launch plan with its potential U.S. partner as the FDA reviews its submission. EOFlow currently has negotiations ongoing with potential distribution partners in the U.S. It expects to strike a deal within the first half of 2023.

“I am very proud to begin the U.S. clearance process,” said EOFlow founder and CEO Jesse J. Kim. “With this submission, we have taken a major step forward in entering the world’s largest diabetes market. Furthermore, as the 510(k) device shares a common backplane with all EOFlow products, this submission is an important step in our efforts to commercialize extended-wear and closed-loop systems in the U.S.”

EOFlow also recently announced that it developed a seven-da wearable pump prototype. It plans to move it to productization.

This pump has a 3 mL reservoir and utilizes EOFlow’s low-power, high-performance pumping technology. The company dubbed it the “EOPatch 3.0.” EOFlow aims for a 2024 launch.

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Technology Tagged With: eoflow, FDA

IN CASE YOU MISSED IT

  • Elixir Medical reports sustained durability with bioadaptor compared to Medtronic stent
  • Senseonics closes public offering, private placement with Abbott
  • Embecta eyes shift from insulin delivery to broader medical supplies focus
  • Medtronic earns expanded CE mark for Prevail paclitaxel-coated balloon
  • Sequel Med Tech to pair automated insulin delivery system with Abbott’s future dual glucose-ketone sensor

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS